March 13, 2014 article Open access Complement Is Activated by IgG Hexamers Assembled at the Cell Surface Science DOI: 10.1126/science.1248943 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 38 stored of 802 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Complement is activated by elevated IgG3 hexameric platforms and deposits C4b onto distinct antibody domains 2023 Nature Communications article Immunology and Microbiology Complement system in diseases Open access cited by 2 patents 50 citations The unique properties of IgG4 and its roles in health and disease 2023 Nature reviews. Immunology review Medicine Monoclonal and Polyclonal Antibodies Research Open access cited by 7 patents 264 citations Factors affecting IgG4-mediated complement activation 2023 Frontiers in Immunology article Immunology and Microbiology Complement system in diseases Open access 56 citations mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine 2023 Frontiers in Immunology article Medicine SARS-CoV-2 and COVID-19 Research Open access 91 citations Logic-gated antibody pairs that selectively act on cells co-expressing two antigens 2022 Nature Biotechnology article Medicine Monoclonal and Polyclonal Antibodies Research Open access cited by 7 patents 49 citations Avidity in antibody effector functions and biotherapeutic drug design 2022 Nature Reviews Drug Discovery review Medicine Monoclonal and Polyclonal Antibodies Research Open access cited by 1 patent 267 citations At Critically Low Antigen Densities, IgM Hexamers Outcompete Both IgM Pentamers and IgG1 for Human Complement Deposition and Complement-Dependent Cytotoxicity 2022 The Journal of Immunology article Immunology and Microbiology Complement system in diseases Open access 27 citations Fc galactosylation of anti-platelet human IgG1 alloantibodies enhances complement activation on platelets 2022 Haematologica article Medicine Blood groups and transfusion Open access 36 citations A bioassay for neuromuscular junction-restricted complement activation by myasthenia gravis acetylcholine receptor antibodies 2022 Journal of Neuroscience Methods article Medicine Myasthenia Gravis and Thymoma Open access 17 citations Biophysical Characterization and Stability of Modified IgG1 Antibodies with Different Hexamerization Propensities 2022 Journal of Pharmaceutical Sciences article Medicine Monoclonal and Polyclonal Antibodies Research Open access 13 citations The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common Diseases? 2021 Journal of Clinical Medicine article Immunology and Microbiology Complement system in diseases Open access 50 citations Fc Galactosylation Promotes Hexamerization of Human IgG1, Leading to Enhanced Classical Complement Activation 2021 The Journal of Immunology article Medicine Monoclonal and Polyclonal Antibodies Research Open access cited by 1 patent 88 citations C1q binding to surface-bound IgG is stabilized by C1r 2 s 2 proteases 2021 Proceedings of the National Academy of Sciences article Immunology and Microbiology Complement system in diseases Open access cited by 1 patent 62 citations C1q binding to surface-bound IgG is stabilized by C1r 2 s 2 proteases 2021 bioRxiv (Cold Spring Harbor Laboratory) preprint Immunology and Microbiology Complement system in diseases Open access 1 citations Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies 2020 HemaSphere article Medicine Monoclonal and Polyclonal Antibodies Research Open access 12 citations Dual Epitope Targeting and Enhanced Hexamerization by DR5 Antibodies as a Novel Approach to Induce Potent Antitumor Activity Through DR5 Agonism 2020 Molecular Cancer Therapeutics article Medicine Monoclonal and Polyclonal Antibodies Research Open access cited by 9 patents 54 citations Biological and structural characterization of murine TRALI antibody reveals increased Fc-mediated complement activation 2020 Blood Advances article Immunology and Microbiology Complement system in diseases Open access 17 citations DuoHexaBody-CD37®, a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies 2020 Blood Cancer Journal article Medicine Monoclonal and Polyclonal Antibodies Research Open access cited by 5 patents 71 citations 21–38 of 38 ← Previous Page 2 / 2 Cited by imported patents 1 (EPO, DOI in their cited literature) SELECTION AND CHARACTERIZATION OF A PEPTIDE-BASED COMPLEMENT ACTIVATOR 2025 NL2037390B1 granted Chemistry & metallurgy 1 office References 0